ES2160090B1 - Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration - Google Patents

Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration

Info

Publication number
ES2160090B1
ES2160090B1 ES200000635A ES200000635A ES2160090B1 ES 2160090 B1 ES2160090 B1 ES 2160090B1 ES 200000635 A ES200000635 A ES 200000635A ES 200000635 A ES200000635 A ES 200000635A ES 2160090 B1 ES2160090 B1 ES 2160090B1
Authority
ES
Spain
Prior art keywords
cyprofloxacin
otitis
aqueous
single dose
comprises single
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200000635A
Other languages
Spanish (es)
Other versions
ES2160090A1 (en
Inventor
Soler Pedro Canovas
Ramon Amat Elisabet De
Rueda Juan Moreno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vita Invest SA
Original Assignee
Vita Invest SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest SA filed Critical Vita Invest SA
Priority to ES200000635A priority Critical patent/ES2160090B1/en
Publication of ES2160090A1 publication Critical patent/ES2160090A1/en
Application granted granted Critical
Publication of ES2160090B1 publication Critical patent/ES2160090B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The set of aqueous cyprofloxacin otitis pharmaceuticals comprising single-dose products for treatment of perforated-eardrum patients, is new. Also claimed is a process utilizing the products in the form of droplets, topically, from single-dose containers.
ES200000635A 2000-03-16 2000-03-16 Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration Expired - Fee Related ES2160090B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES200000635A ES2160090B1 (en) 2000-03-16 2000-03-16 Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000635A ES2160090B1 (en) 2000-03-16 2000-03-16 Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration

Publications (2)

Publication Number Publication Date
ES2160090A1 ES2160090A1 (en) 2001-10-16
ES2160090B1 true ES2160090B1 (en) 2002-07-01

Family

ID=8492728

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200000635A Expired - Fee Related ES2160090B1 (en) 2000-03-16 2000-03-16 Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration

Country Status (1)

Country Link
ES (1) ES2160090B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050159369A1 (en) * 2003-08-20 2005-07-21 Qtm Llc Method of treatment of otitis externa

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2088742B1 (en) * 1994-06-29 1997-03-16 Salvat Lab Sa ANTIBIOTIC COMPOSITION OF OTIC APPLICATION.
US5843930A (en) * 1995-06-06 1998-12-01 Bayer Corporation Method of treating otitis with ciprofloxacin-hydrocortisone suspension
DE69620136T2 (en) * 1995-06-06 2002-08-01 Bayer Ag ANTIBACTERIAL PREPARATIONS FOR THE EARS WITHOUT IRRITATING, SENSITIZING AND OTOTOXIC EFFECTS
IT1280428B1 (en) * 1995-07-14 1998-01-20 R R A S R L PHARMACEUTICAL COMPOSITION FOR TOPICAL USE
ES2105971B1 (en) * 1995-08-02 1998-07-01 S A L V A T Lab Sa ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION.
ES2105970B1 (en) * 1995-08-02 1998-07-01 S A L V A T Lab Sa ORAL PHARMACEUTICAL COMPOSITION OF CIPROFLOXACINO, NON-AQUEOUS, STABLE AND WITH IMPROVED ORGANOLEPTIC CHARACTERISTICS.
ES2106680B1 (en) * 1995-08-03 1998-07-01 Vita Invest Sa AQUEOUS COMPOSITIONS CONTAINING CIPROFLOXACINO AND CORRESPONDING USE AND PROCEDURE.

Also Published As

Publication number Publication date
ES2160090A1 (en) 2001-10-16

Similar Documents

Publication Publication Date Title
UA74346C2 (en) Aminodicarboxylic acids derivatives, use thereof and a medicament
MX9602683A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutically active substances.
MX9601399A (en) Benzocyclopentane oxazolidones containing heteroatoms, process for their production and medicaments containing them.
CA2257329A1 (en) Nebulized budesonide for the treatment of respiratory diseases
CA2272584A1 (en) Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
MXPA03007712A (en) Pharmaceutical salts.
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
ATE205086T1 (en) USE OF THE CHELATING AGENT CLIOQUINOL FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ALZHEIMER'S DISEASE
WO2001085715A3 (en) Aza- and polyazanthranyl amides and their use as medicaments
AU1122202A (en) Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis
HU9602668D0 (en) Progesterone antagonists useful preparing medicaments for treating dysfunctional uterine bleeding
IS2135B (en) Medicinal product containing solmitriptan
IL150528A0 (en) Ibuprofen containing active agent preparation
AU5372199A (en) Cyclopentabenzofuran derivatives and their use
MA26899A1 (en) PREPARATIONS CONTAINING A GLUCOCORTICOID MEDICAMENT FOR THE TREATMENT OF BRONCHOPULMONARY DISEASES.
WO2000062798A3 (en) Angiogenic growth factors for treatment of peripheral neuropathy
PL348781A1 (en) Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition
GB9909135D0 (en) Cystic fibrosis medicaments
ES2160090B1 (en) Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration
WO2002053149A3 (en) Medicament containing a polyamine as an active substance
NZ334571A (en) Pharmaceutical composition comprising 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy-acetic acid for treating diseases induced by respiratory syncytial virus
WO2001076590A3 (en) Treatment for benign positional vertigo using antiepileptics
DE69941897D1 (en) MEDICINAL PRODUCT FOR NON-CARDIOGENIC DIASTOLIC DYSFUNCTION
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
WO2002041897A3 (en) Novel pharmaceutical compositions with anti-diabetic activity and method for preparing same

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20011016

Kind code of ref document: A1

Effective date: 20011016

FD2A Announcement of lapse in spain

Effective date: 20200626